Considering sex and gender in medical research: insights from the lead author of the SAGER guidelines
Read Shirin Heidari’s thoughts on the importance of incorporating sex and gender dimensions in clinical research design and reporting.
Quantifying authorship in clinical trial publications – a new algorithm
Learn about a new decision support tool developed to supplement the ICMJE criteria and GPP3 guidelines.
How to preprint properly: updated guidance from the ICMJE
Find out more about ICMJE’s latest recommendations on the use of preprints in scientific publishing.
Meeting report: summary of Day 2 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Meeting report: summary of Day 1 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
How can we improve plain language summaries?
See how expert stakeholders think the key issues with plain language summaries can be overcome.
New CONSORT extension for trials using cohorts and routinely collected data: CONSORT-ROUTINE
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
PRISMA-S: guidance for reporting literature search methods for systematic reviews published
The PRISMA-S checklist aims to ensure transparent reporting and maximum reproducibility of literature searches performed as part of systematic reviews.
Meeting report: summary of session 1 of the 9th EMWA symposium
Missed the meeting? Read our report to get up to speed!
Is the quality of scientific reporting in preprints up to the peer review standard?
Find out if preprints are up to scratch when it comes to transparent reporting and whether traditional peer review can raise the bar higher.
Acknowledging professional writing support in publications – are we doing enough?
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
Updated guidelines for reporting systematic reviews: the PRISMA 2020 statement
Get up to speed with the recently published PRISMA 2020 statement, which contains updated guidelines for reporting systematic reviews.
New artificial intelligence-specific extension to the SPIRIT guidelines published
A new SPIRIT extension aims to ensure high-quality reporting of published trial protocols of interventions with an artificial intelligence component.
PRISMA-DTA elaboration paper: making diagnostic test accuracy systematic reviews more useful
The BMJ publishes an explanation article to aid interpretation of the PRISMA-DTA reporting guidelines.
SPENT: new guidelines for reporting n-of-1 trial protocols
An extension and elaboration of the SPIRIT checklist specific to n-of-1 trials aims to improve the quality and reporting of protocols for this trial type.
Reporting of many clinical trials ruled illegal
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.